Our Analysts

Ben Bahavar, Ph.D.

Ben Bahavar, Ph.D., advises companies focused on stepping out to adjacent markets where they could apply their core technologies in new ways. He brings particular insight by synthesizing information from technology evaluations (patent and non-patent), competitive intelligence, and market elements. Read more.

Erica Kramer, Ph.D.

Dr. Erica Kramer works primarily with the Medical Device team at Nerac conducting research of clinical literature, preparing clinical literature evaluations, and conducting focused research to address clients’ questions relating to the medical device industry. Read more.

 

Jeffrey Magee, BSME, MBA

Jeffrey Magee, BSME & MBA, helps clients identify, secure and expand their intellectual property assets while defining market niches using engineering and business metrics. Read more.

 

Helga Weires

Analyst Helga Weires works with medical device manufacturers, academics, and individual physicians from around the world developing diagnostic and therapeutic devices. She guides clients through technical and intellectual property issues regarding medical devices for all branches of medicine, including orthopedics, cardiology and internal medicine. Read more.

Minh Han, MD, FAAFP

Dr. Minh Han is part of the medical device regulatory team at Nerac evaluating clinical literature, drafting clinical evaluation plans (CEPs), and preparing clinical evaluation reports (CERs), with a particular focus on State of the Art. Read more.

 

Miriam Sharif-Murray, M.S.

Miriam Sharif-Murray brings over 20 years of medical device/regulatory experience to Nerac clients. After completing her degrees, she worked as a chemist for chemical and medical device manufacturers where she further strengthened her scientific knowledge and built her expertise in the regulatory environment. Read more.

 

Priscilla S. Monarca, M.P.H.

Priscilla S. Monarca, M.P.H., is a member of the medical device regulatory team at Nerac and works with medical device companies to provide client-specific services, including literature reviews, report preparation and other research and support services to meet client needs. Read more.

 

Richard Hendriks, Ph.D.

Analyst Richard Hendriks, Ph.D., partners with pharmaceutical and biotech companies to discover the most effective ways of meeting their business goals. This encompasses a range of solutions from innovations in biotechnology to analytical assessments of recent treatment advances. Read more.

 

Richard Maldanis, Ph.D.

For over a decade, Richard Maldanis, Ph.D. has been assisting Nerac clients in the specialty chemistry and material science fields. His diverse expertise in organic, inorganic, organometallic and polymer chemistry provides clients with solutions to a broad range of chemistry-related challenges. Read more.

 

Rosemarie Szostak, Ph.D.

Analyst Rosemarie Szostak, Ph.D., advises companies on technology, patents, innovation and disruptive technology. She has 20 plus years as a thought leader and analyst with broad technical knowledge in chemistry, materials and chemical engineering. Read more.

Sarah McLeod, M.S.

Analyst Sarah McLeod, M.S., consults with medical device and biomedical companies to discover the most effective ways of meeting their research data quality objectives. This encompasses a range of interventions from training clinical research staff in data acquisition to monitoring clinicians for protocol adherence to reporting clinically significant outcomes for study report inclusion. Read more.